Boyer M - Search Results

1

Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial.

Park K, Tan EH, O'Byrne K, Zhang L, Boyer M, Mok T, Hirsh V, Yang JC, Lee KH, Lu S, Shi Y, Kim SW, Laskin J, Kim DW, Arvis CD, Kölbeck K, Laurie SA, Tsai CM, Shahidi M, Kim M, Massey D, Zazulina V, Paz-Ares L. Park K, et al. Among authors: boyer m. Lancet Oncol. 2016 May;17(5):577-89. doi: 10.1016/S1470-2045(16)30033-X. Epub 2016 Apr 12. Lancet Oncol. 2016. PMID: 27083334 Clinical Trial.

2

Recent advances in managing non-small-cell lung cancer: 4. Chemotherapy of metastatic cancer.

Clarke SJ, Boyer MJ. Clarke SJ, et al. Among authors: boyer mj. Med J Aust. 1997 Jun 2;166(S1):S14-6. Med J Aust. 1997. PMID: 9201199

3

Phase I study of paclitaxel and oral etoposide in previously untreated non-small-cell and extensive small-cell lung cancer.

Boyer MJ, Zalcberg J, Olver IN, Millward MJ, Richardson G, McKeage MJ. Boyer MJ, et al. Ann Oncol. 1997 May;8(5):485-9. doi: 10.1023/a:1008291606695. Ann Oncol. 1997. PMID: 9233529 Free article. Clinical Trial.

4

Non-surgical therapy for patients with advanced non-small cell lung cancer.

Clarke SJ, Boyer MJ. Clarke SJ, et al. Among authors: boyer mj. Respirology. 1998 Sep;3(3):175-82. doi: 10.1111/j.1440-1843.1998.tb00117.x. Respirology. 1998. PMID: 9767616 Review.

5

Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer.

Boyer MJ, Mitchell P, Goldstein D, Millward MJ, Olver IN, Clarke SJ, Richardson G, Davis I. Boyer MJ, et al. Lung Cancer. 2001 Apr;32(1):89-94. doi: 10.1016/s0169-5002(00)00207-5. Lung Cancer. 2001. PMID: 11282433 Clinical Trial.

6

Phase II trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancer.

Clarke SJ, Abratt R, Goedhals L, Boyer MJ, Millward MJ, Ackland SP. Clarke SJ, et al. Among authors: boyer mj. Ann Oncol. 2002 May;13(5):737-41. doi: 10.1093/annonc/mdf115. Ann Oncol. 2002. PMID: 12075742 Free article. Clinical Trial.

7

Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients.

Millward MJ, Boyer MJ, Lehnert M, Clarke S, Rischin D, Goh BC, Wong J, McNeil E, Bishop JF. Millward MJ, et al. Among authors: boyer mj. Ann Oncol. 2003 Mar;14(3):449-54. doi: 10.1093/annonc/mdg118. Ann Oncol. 2003. PMID: 12598352 Free article. Clinical Trial.

8

Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer.

Viney RC, Boyer MJ, King MT, Kenny PM, Pollicino CA, McLean JM, McCaughan BC, Fulham MJ. Viney RC, et al. Among authors: boyer mj. J Clin Oncol. 2004 Jun 15;22(12):2357-62. doi: 10.1200/JCO.2004.04.126. J Clin Oncol. 2004. PMID: 15197196 Clinical Trial.

9

Phase II trial of gemcitabine-carboplatin-paclitaxel as neoadjuvant chemotherapy for operable non-small cell lung cancer.

Abratt RP, Lee JS, Han JY, Tsai CM, Boyer M, Mok T, Kim SW, Lee JS, Brnabic AJ, Reece WH, Lehnert M. Abratt RP, et al. Among authors: boyer m. J Thorac Oncol. 2006 Feb;1(2):135-40. J Thorac Oncol. 2006. PMID: 17409842 Free article. Clinical Trial.

10

Quality of life and survival in the 2 years after surgery for non small-cell lung cancer.

Kenny PM, King MT, Viney RC, Boyer MJ, Pollicino CA, McLean JM, Fulham MJ, McCaughan BC. Kenny PM, et al. Among authors: boyer mj. J Clin Oncol. 2008 Jan 10;26(2):233-41. doi: 10.1200/JCO.2006.07.7230. Epub 2007 Dec 17. J Clin Oncol. 2008. PMID: 18086802

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

931 results

Search Page

Filters